Brief: Scancell Holdings Says Cash Runway Through To Early 2025 Achieving Near-Term Clinical Milestones For Scib1 And Modi-1
31/10/2023 07:31
Oct 31 (Reuters) - Scancell Holdings PLC SCLP.L :
* OPERATING LOSS FOR 12-MONTH PERIOD TO 30 APRIL 2023 £11.9
MILLION VERSUS OPERATING LOSS £13.3 MILLION
* GROUP CASH BALANCE AT 30 APRIL 2023 WAS £19.9 MILLION
* CASH RUNWAY THROUGH TO EARLY 2025 ACHIEVING NEAR-TERM
CLINICAL
MILESTONES FOR SCIB1 AND MODI-1
* EARLY CLINICAL DATA WITH MODI-1 EXPECTED TO BE AVAILABLE
IN 2024
((Reuters.Briefs@thomsonreuters.com;;))